Transcat (NASDAQ:TRNS) Lowered to Sell Rating by StockNews.com

StockNews.com downgraded shares of Transcat (NASDAQ:TRNS) from a hold rating to a sell rating in a research report released on Wednesday morning.

A number of other equities research analysts also recently issued reports on TRNS. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Northland Securities restated a “market perform” rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. HC Wainwright reduced their price target on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Finally, Craig Hallum increased their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $111.50.

Transcat Stock Down 0.6 %

Shares of Transcat stock opened at $78.85 on Wednesday. The stock has a market cap of $725.42 million, a price-to-earnings ratio of 42.62 and a beta of 0.68. Transcat has a twelve month low of $73.37 and a twelve month high of $147.12. The company’s fifty day moving average is $101.40 and its 200 day moving average is $112.73.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same period last year, the firm posted $0.56 EPS. As a group, equities analysts anticipate that Transcat will post 2.3 earnings per share for the current fiscal year.

Insider Activity

In other Transcat news, Director Craig D. Cairns bought 1,200 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were bought at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the transaction, the director now directly owns 1,910 shares in the company, valued at $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Transcat

Hedge funds and other institutional investors have recently modified their holdings of the stock. The Manufacturers Life Insurance Company raised its position in Transcat by 8.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,312 shares of the scientific and technical instruments company’s stock valued at $396,000 after purchasing an additional 263 shares during the last quarter. Diversified Trust Co boosted its holdings in Transcat by 34.6% in the third quarter. Diversified Trust Co now owns 3,985 shares of the scientific and technical instruments company’s stock valued at $481,000 after acquiring an additional 1,025 shares in the last quarter. Annex Advisory Services LLC increased its position in Transcat by 61.4% during the 3rd quarter. Annex Advisory Services LLC now owns 16,568 shares of the scientific and technical instruments company’s stock valued at $2,001,000 after purchasing an additional 6,304 shares during the period. Essex Investment Management Co. LLC lifted its position in shares of Transcat by 0.4% in the 3rd quarter. Essex Investment Management Co. LLC now owns 43,444 shares of the scientific and technical instruments company’s stock worth $5,247,000 after purchasing an additional 171 shares during the period. Finally, nVerses Capital LLC bought a new stake in shares of Transcat during the 3rd quarter valued at about $60,000. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.